ASCO 2018 - Riley Ennis about their AI genomics platform

At ASCO 2018, Riley Ennis, COO and co-founder of Freenome, highlights how Freenome is using their AI genomics platform enabling sequencing and analysis of multiple analytes to evaluate genomic, proteomic and epigenetic changes. He also discusses how QIAGEN products feature in Freenome’s lab workflow and what the companies plan to offer under a cooperation agreement that was announced on May 31, 2018.